Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective neoadjuvant therapy of rectal cancer patients (SELREC): study protocol for a European randomised controlled, open, multicentre non-inferiority trial.

BMJ open·2025
Same author

Stapler versus scalpel resection followed by handsewn closure of the pancreatic remnant for distal pancreatectomy.

The Cochrane database of systematic reviews·2025
Same author

[Risky hospital plan-A survey of head physicians in NRW: dramatic effects in visceral surgery].

Chirurgie (Heidelberg, Germany)·2025
Same author

Ghost-ileostomy versus conventional loop ileostomy in patients undergoing low anterior resection for rectal cancer: results of a randomised controlled multicentre pilot trial (DRKS00013997).

Langenbeck's archives of surgery·2024
Same author

[Outpatient treatment for hernia surgery in Germany].

Chirurgie (Heidelberg, Germany)·2024
Same author

Pre-Surgery Inflammatory and Angiogenesis Biomarkers as Predictors of 12-Month Cancer-Related Distress: Results from the ColoCare Study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2023

Related Experiment Video

Updated: Mar 24, 2026

Laparoscopic Radical Antegrade Modular Pancreatosplenectomy via Dorsal-Caudal Artery Approach for Pancreatic Neck-Body Cancer
12:07

Laparoscopic Radical Antegrade Modular Pancreatosplenectomy via Dorsal-Caudal Artery Approach for Pancreatic Neck-Body Cancer

Published on: November 18, 2022

4.8K

Borderline resectable pancreatic cancer.

Thilo Hackert1, Alexis Ulrich1, Markus W Büchler1

  • 1Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Im Neuenheimer Feld 110, 69120 Heidelberg, Germany.

Cancer Letters
|March 13, 2016
PubMed
Summary
This summary is machine-generated.

Borderline resectable pancreatic cancer requires careful management. This review covers the definition, treatment options, and outcomes for borderline resectable pancreatic ductal adenocarcinoma (BR-PDAC).

Keywords:
Borderline resectablePancreatic cancerTherapy

More Related Videos

Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique
08:12

Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique

Published on: February 2, 2022

2.8K
An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

13.0K

Related Experiment Videos

Last Updated: Mar 24, 2026

Laparoscopic Radical Antegrade Modular Pancreatosplenectomy via Dorsal-Caudal Artery Approach for Pancreatic Neck-Body Cancer
12:07

Laparoscopic Radical Antegrade Modular Pancreatosplenectomy via Dorsal-Caudal Artery Approach for Pancreatic Neck-Body Cancer

Published on: November 18, 2022

4.8K
Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique
08:12

Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique

Published on: February 2, 2022

2.8K
An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

13.0K

Area of Science:

  • Oncology
  • Surgical Oncology
  • Gastroenterology

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) treatment relies on surgery and chemotherapy for long-term survival.
  • Advanced surgical techniques now enable resection of borderline resectable PDAC (BR-PDAC).
  • BR-PDAC management is controversial, debating upfront resection versus neoadjuvant therapy.

Purpose of the Study:

  • To review the current definition and management strategies for BR-PDAC.
  • To discuss the outcomes associated with different BR-PDAC treatment approaches.
  • To highlight the importance of preoperative diagnostics and surgical expertise.

Main Methods:

  • Literature review of current studies on BR-PDAC.
  • Analysis of surgical and interdisciplinary management protocols.
  • Discussion of ongoing and future research in neoadjuvant treatment for PDAC.

Main Results:

  • Accurate preoperative assessment is crucial for determining PDAC resectability.
  • Borderline resectable status necessitates specialized surgical and interdisciplinary care.
  • Neoadjuvant treatment strategies are evolving for BR-PDAC.

Conclusions:

  • Optimal management of BR-PDAC involves a multidisciplinary approach.
  • Further research is needed to refine neoadjuvant therapies and surgical decision-making for BR-PDAC.
  • Improved diagnostic accuracy and surgical expertise enhance outcomes for resectable PDAC.